Literature DB >> 16109243

[Microglia--biology and relevance to disease].

Martin Wirenfeldt1, Rune Ladeby, Ishar Dalmau, Richard B Banati, Bente Finsen.   

Abstract

Microglia, the resting macrophage population in the brain and spinal cord, has a central role in inflammatory processes and in acute and chronic degenerative diseases of the central nervous system. The possibility of utilizing microglia diagnostically has emerged with the prospect of visualization of reactive microgliosis via positron emission tomography. Microglia might also have a therapeutic potential by way of recruitment of microglial precursors from the blood with the opportunity to introduce genetically modified cells lesion-specifically into the central nervous system via the bloodstream. Knowledge about microglial function has preferentially been obtained via studies in experimental animal models of the pathological central nervous system. In spite of the rather extensive knowledge regarding the pathophysiological implications of these cells, their function in the normal central nervous system remains rather unknown.

Entities:  

Mesh:

Year:  2005        PMID: 16109243

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  3 in total

1.  Brief exposure to hyperoxia depletes the glial progenitor pool and impairs functional recovery after hypoxic-ischemic brain injury.

Authors:  Joshua D Koch; Darryl K Miles; Jennifer A Gilley; Cui-Ping Yang; Steven G Kernie
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-12       Impact factor: 6.200

2.  Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells.

Authors:  Yung Hyun Choi; Hye Young Park
Journal:  J Biomed Sci       Date:  2012-03-20       Impact factor: 8.410

3.  Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.

Authors:  Dong-Cheol Kim; Chi-Su Yoon; Tran Hong Quang; Wonmin Ko; Jong-Su Kim; Hyuncheol Oh; Youn-Chul Kim
Journal:  Int J Mol Sci       Date:  2016-02-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.